Duchenne UK has partnered with one of the world’s leading gene therapy teams focusing on AAV immunology. Drs. Manuela Corti and Barry Byrne at the Powell Gene Therapy Center, University of Florida, will try to temporarily modify the immune system so that anybody can be treated with gene therapy, and, if necessary, can receive repeat doses.
“We are excited to collaborate with Duchenne UK and to take the next step in fulfilling our commitment to patients and families living with Duchenne Muscular Dystrophy (DMD). This project is an important milestone in the development of a successful gene therapy treatment that could dramatically improve the quality of life for patients with DMD of all ages to ensure durability and safety,” Dr. Byrne said.Learn more about University of Florida Received £500,000 Grant From Duchenne UK to Overcome Immunity Challenges in Gene Therapy.